About Tata India Pharma & Healthcare Fund
Tata India Pharma & Healthcare Fund is a sectoral / thematic fund managed by Tata Mutual Fund. Invest in one sector (such as banking, IT or pharma) or a theme (such as consumption or infrastructure). Concentrated and higher risk; suited to investors with a view on that sector.
The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
The scheme's stated objective, as published by Tata Mutual Fund.
The NAV (net asset value) is the price of one unit of the fund. It is published by the fund house every business day and changes with the value of the fund's holdings. The Growth option reinvests all gains, so its NAV reflects the fund's total return.
Tax on your gains
Gains are taxed as equity: sell within 12 months and the gain is short-term, taxed at 20%. Hold longer and it is long-term, taxed at 12.5% on gains above ₹1.25 lakh in a financial year, across all your equity investments.
Work out what you would owe with the capital gains tax calculator.
Every plan and option, with scheme codes
| Plan | Option | NAV | Scheme code |
|---|---|---|---|
| Direct | Growth Option | ₹39.5025 | 135810 |
| Direct | Payout of Income Distribution cum capital withdrawal option | ₹38.2185 | 135807 |
| Direct | Reinvestment of Income Distribution cum capital withdrawal option | ₹38.2185 | 135808 |
| Regular | Growth Option | ₹33.3996 | 135812 |
| Regular | Payout of Income Distribution cum capital withdrawal option | ₹32.1218 | 135809 |
| Regular | Reinvestment of Income Distribution cum capital withdrawal option | ₹32.1218 | 135811 |
Frequently asked questions
What is the NAV of Tata India Pharma & Healthcare Fund today?
The NAV of Tata India Pharma & Healthcare Fund (Direct plan, Growth) is ₹39.5025 and the Regular plan NAV is ₹33.3996, as of 18 Sept 2026.
What returns has Tata India Pharma & Healthcare Fund given?
Over the last year the Direct plan returned 9.24%, and 19.81% a year over 3 years and 14.71% a year over 5 years. That places it 24 of 136 funds in its category over 3 years. Past returns do not guarantee future returns.
What is the expense ratio of Tata India Pharma & Healthcare Fund?
The Direct plan charges 0.97% a year, as disclosed on 31 Jul 2026. The fee is already taken out of the NAV, so the returns above are what you keep.
What is the minimum SIP amount in Tata India Pharma & Healthcare Fund?
You can start a monthly SIP with ₹100, or invest a lump sum of ₹5,000 or more.
How much has Tata India Pharma & Healthcare Fund fallen in the past?
Its deepest fall was 18.5% from 19 Feb 2020 to 23 Mar 2020. Of every one-year stretch in its history, 76% ended in a gain.
Which category does Tata India Pharma & Healthcare Fund belong to?
It is a Sectoral / Thematic Fund from Tata Mutual Fund. Invest in one sector (such as banking, IT or pharma) or a theme (such as consumption or infrastructure). Concentrated and higher risk; suited to investors with a view on that sector.
What is the difference between the Direct and Regular plan?
Both invest in the same portfolio. The Direct plan is bought straight from the fund house or a direct platform and has a lower expense ratio because no distributor commission is paid, so its NAV grows slightly faster over time.
How are gains from Tata India Pharma & Healthcare Fund taxed?
Gains are taxed as equity: sell within 12 months and the gain is short-term, taxed at 20%. Hold longer and it is long-term, taxed at 12.5% on gains above ₹1.25 lakh in a financial year, across all your equity investments.
Source: NAVs published by the fund house through AMFI. Mutual fund investments are subject to market risks; read all scheme-related documents carefully. Past performance does not guarantee future returns. This page is for information only and is not a recommendation to buy or sell.